Free Trial

Amplify Weight Loss Drug & Treatment ETF Rating

$25.33
+0.03 (+0.12%)
(As of 11/1/2024 ET)

Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

THNR Aggregate Rating

Moderate Buy
2.79

Holdings in THNR have an aggregate rating of Moderate Buy based on 184 analyst ratings issued in the past year covering 16 companies (69.4% of the portfolio).

THNR Aggregate Price Target

$32.25
27.36% Upside
High Prediction$38.99
Average Prediction$32.25
Low Prediction$24.73

Holdings in THNR have an aggregate price target of $32.25 and a range of $24.73 to $38.99 covering 16 companies (69.4% of the portfolio).

THNR Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
Moderate Buy
12 Moderate Buy rating(s)
Hold
1 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 16 THNR Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
15.26%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$818.93
-1.3%
4.9036 of 5 stars
2.84$1,009.00 23.2%19Earnings Report
Dividend Announcement
Analyst Forecast
Analyst Revision
13.43%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$111.94
0.0%
4.3935 of 5 stars
2.86$144.50 29.1%7Upcoming Earnings
Analyst Upgrade
Options Volume
5.19%
Pfizer Inc. stock logo
PFE
Pfizer
$28.09
-0.7%
4.9889 of 5 stars
2.60$33.58 19.6%15Earnings Report
Analyst Upgrade
Analyst Revision
5.13%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$71.42
+0.4%
4.4132 of 5 stars
2.91$89.75 25.7%11Analyst Revision
5.08%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$557.92
+2.1%
4.964 of 5 stars
2.86$649.33 16.4%22Insider Selling
5.05%
Amgen Inc. stock logo
AMGN
Amgen
$319.22
-0.3%
4.5959 of 5 stars
2.50$333.50 4.5%24Earnings Report
Dividend Announcement
Analyst Forecast
Analyst Revision
4.89%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$101.88
-0.4%
4.9993 of 5 stars
2.88$129.93 27.5%17Earnings Report
Analyst Forecast
News Coverage
3.72%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$316.50
+2.8%
4.8904 of 5 stars
2.67$460.33 45.4%3Insider Selling
3.58%
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
$18.45
+0.1%
1.5194 of 5 stars
2.78$19.67 6.6%9Upcoming Earnings
News Coverage
2.59%
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$72.88
+0.5%
4.1445 of 5 stars
3.09$108.60 49.0%11
2.46%
Structure Therapeutics Inc. stock logo
GPCR
Structure Therapeutics
$41.14
0.0%
1.7735 of 5 stars
3.00$86.80 111.0%6
1.88%
Catalent, Inc. stock logo
CTLT
Catalent
$58.73
+0.2%
3.1186 of 5 stars
2.00$59.83 1.9%8
0.64%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$20.36
+8.1%
2.6756 of 5 stars
2.50$20.21 -0.7%16Upcoming Earnings
Insider Selling
Analyst Revision
0.18%
OPKO Health, Inc. stock logo
OPK
OPKO Health
$1.51
4.6555 of 5 stars
3.00$2.75 82.1%3Upcoming Earnings
News Coverage
0.18%
Altimmune, Inc. stock logo
ALT
Altimmune
$6.74
1.804 of 5 stars
2.86$18.80 178.9%7Upcoming Earnings
0.13%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$6.94
+1.2%
4.6147 of 5 stars
2.83$26.92 287.8%6Analyst Forecast
News Coverage

This page (NYSEARCA:THNR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners